Authors:
Pinto, DJP
Orwat, MJ
Wang, SG
Fevig, JM
Quan, ML
Amparo, E
Cacciola, J
Rossi, KA
Alexander, RS
Smallwood, AM
Luettgen, JM
Liang, L
Aungst, BJ
Wright, MR
Knabb, RM
Wong, PC
Wexler, RR
Lam, PYS
Citation: Djp. Pinto et al., Discovery of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2 '- (methylsulfonyl)-[1,1 '-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa, J MED CHEM, 44(4), 2001, pp. 566-578
Authors:
Galemmo, RA
Wells, BL
Rossi, KA
Alexander, RS
Dominguez, C
Maduskuie, TP
Stouten, PFW
Wright, MR
Aungst, BJ
Wong, PC
Knabb, RM
Wexler, RR
Citation: Ra. Galemmo et al., The de novo design and synthesis of cyclic urea inhibitors of factor Xa: Optimization of the S4 ligand, BIOORG MED, 10(3), 2000, pp. 301-304
Authors:
Nakayama, A
Saitoh, H
Oda, M
Takada, M
Aungst, BJ
Citation: A. Nakayama et al., Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system, EUR J PH SC, 11(4), 2000, pp. 317-324
Authors:
Aungst, BJ
Nguyen, NH
Bulgarelli, JP
Oates-Lenz, K
Citation: Bj. Aungst et al., The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds, PHARM RES, 17(10), 2000, pp. 1175-1180
Citation: H. Saitoh et Bj. Aungst, Improvement of the intestinal absorption of a peptidomimetic, boronic acidthrombin inhibitor possibly utilizing the oligopeptide transporter, PHARM RES, 16(11), 1999, pp. 1786-1789
Citation: Bj. Aungst, P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs, ADV DRUG DE, 39(1-3), 1999, pp. 105-116